- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 148 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- January 2025
- 139 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- February 2025
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- November 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- November 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 187 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 187 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 250 Pages
Global
From €4752EUR$4,999USD£3,992GBP

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient.
Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more